The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia. (Record no. 26079106)

MARC details
000 -LEADER
fixed length control field 00795 a2200205 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517100259.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201606s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2040-6207
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1177/2040620716640422
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Benjamin, Jonathan E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160601
245 00 - TITLE STATEMENT
Title The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Therapeutic advances in hematology
Date of publication, distribution, etc. Jun 2016
300 ## - PHYSICAL DESCRIPTION
Extent 142-56 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stein, Anthony S
773 0# - HOST ITEM ENTRY
Title Therapeutic advances in hematology
Related parts vol. 7
-- no. 3
-- p. 142-56
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1177/2040620716640422">https://doi.org/10.1177/2040620716640422</a>
Public note Available from publisher's website

No items available.